Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo

Signe Borgquist*, Maj Britt Jensen, Cecilie Linea Bendorff, Peer Christiansen, Birgitte Vrou Offersen, Annette Raskov Kodahl, Marianne Ewertz, Anders Bonde Jensen, Thomas P. Ahern, Deirdre Cronin-Fenton, Bent Ejlertsen

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Fingerprint

Dive into the research topics of 'Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases